BusinessEarth Science Tech, Inc. Announces New Agreement with Axcelon Biopolymers Corp. for Distribution of Nanoderm™ Medical Device & Advances with Its MSN-2 Medical DeviceBy Nasdaq OMXSep 19, 2017, 12:45 PM UTC
BusinessTHC Therapeutics Is In The Process Of Becoming Fully Reporting To The SECBy Nasdaq OMXAug 24, 2017, 11:20 AM UTC
BusinessStudy: Physicians Willing to Assess Patients’ Spiritual Needs, More Likely to do so with Education and TrainingBy Nasdaq OMXJul 26, 2017, 2:10 PM UTC
BusinessTHC Therapeutics Will Have an Exhibit and Presentation at The Money Show Las Vegas May 15th - 18thBy Nasdaq OMXApr 24, 2017, 11:20 AM UTC
BusinessParticipate in our $3 million Private Placement to Earn a Potential 20% Return on Investment in THC Therapeutics (THCT) StockBy Nasdaq OMXApr 21, 2017, 11:20 AM UTC
BusinessCrawford Supports Silver Oxysalts™ Speaker Panel at the Symposium for Advanced Wound CareBy Nasdaq OMXApr 13, 2017, 1:03 PM UTC
BusinessThe First Hire Of Our Medical Team! THC Therapeutics Has Hired Dr. John Pierce, The President Of Ageless Forever, As Medical DirectorBy Nasdaq OMXApr 13, 2017, 12:05 PM UTC
